My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Reso 2018-2773
SIBFL
>
City Clerk
>
Resolutions
>
Regular
>
2018
>
Reso 2018-2773
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
1/24/2018 10:58:44 AM
Creation date
1/24/2018 10:52:57 AM
Metadata
Fields
Template:
CityClerk-Resolutions
Resolution Type
Resolution
Resolution Number
2018-2773
Date (mm/dd/yyyy)
01/18/2018
Description
Approve Updates to the Drug-Free Workplace Program Policy
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
45
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
o Methadone 300ng/ml <br /> o Propoxyphene 300ng/ml <br /> *Chemical breath testing procedures as described in Chapter 10D-42, F.A.C. or U. S. <br /> Department of Transportation rules, or other reasonably reliable alcohol test devices, <br /> including tubes containing crystals that change color when exposed to alcohol, passive <br /> alcohol sensors, or saliva testing devices, etc., may be used, as determined by the City <br /> prior to requiring a blood sample in its reasonable suspicion testing program (and <br /> random if such is implemented in the future). These results are reported only to the <br /> appropriate manager who then determines if further testing under this program is <br /> warranted. <br /> L. Confirmation Tests Used for Implementing § 440.101-.102, Fla. Stat. <br /> All blood and urine specimens identified as positive on the initial test will be confirmed <br /> using gas chromatography/mass spectrometry (GC/MS) or an equivalent or more <br /> accurate scientifically accepted method approved by the HRS, except that alcohol will be <br /> confirmed using gas chromatography. All confirmation will be done by quantitative <br /> analysis. Concentrations which exceed the linear region of the standard curve will be <br /> documented in the laboratory and recorded as "greater than highest standard curve <br /> value". The following confirmation cutoff levels will be used when analyzing specimens <br /> to determine whether they are positive or negative for these drugs metabolites. All <br /> levels equal to or exceeding the following will be reported as positive: <br /> • Alcohol .05g/dl% <br /> • Amphetamines 1000ng/ml <br /> • Cannabinoids 100ng/m1 <br /> • Cocaine 300ng/ml <br /> • Phencyclidine 25ng/ml <br /> • Methaqualone 300ng/ml <br /> • Opiates 300ng/ml <br /> • Barbiturates 300ng/ml <br /> • Benzodiazepines 300ng/ml <br /> • Synthetic Narcotics: <br /> o Methadone 300ng/ml <br /> o Propoxyphene 300ng/ml <br /> IX. TEST RESULTS (Blood and Urine) <br /> A. Reporting Results. <br /> 1. The laboratory shall disclose to the MRO a written positive confirmed test results <br /> report within 7 working days after receipt of the sample. The laboratory should report <br /> all test results (both positive and negative) to the Medical Review Officer (MRO) <br /> within 7 working days after receipt of the specimen at the laboratory. The name and <br /> address of the current MRO is on file with the Human Resources Department. The <br /> MRO is employed by the City and is not an employee of the drug testing laboratory. <br /> 2. The laboratory will report as negative all specimens which are negative on the initial <br /> test or negative on the confirmation test. Only specimens confirmed positive on the <br /> confirmation test will be reported positive for a specific drug. <br /> (Reso)Sib Drug-Free Workplace Proeram-Rev 01182018 Page 15 of 41 1/18/2018 <br />
The URL can be used to link to this page
Your browser does not support the video tag.